Cytorex Biosciences, Inc. is a privately held Florida-based Biopharma company with US patented technology to treat cancer using an approach that has never been taken before in drug development: the use of Inorganic Acids as actives.
Our lead compound is called Cytoreg® . We also have other compounds in the pipeline under development for different disease indications such as Skin Cancer, MS, Diabetes, and High Blood Pressure among others.
Cytoreg® is a combination of 4 inorganic acids and 2 organic acids in water, where The Fluoride (F- ion) of hydrofluoric acid is the active agent.
Cytoreg® will target and destroy cancer cells without affecting normal cells, hence becoming a very effective and safe product to administer to human cancer patients, since its has a very low toxicity profile.
The first indication for Cytoreg® is Glioblastoma Multiforme, a malignant brain tumor with a very low cure rate. Cytoreg® will cross the blood brain barrier due to its very low molecular weight.
For More Information Please call us at 954-465-9580/954-573-4006 or email us at email@example.com
©2015. Cytorex International, Inc.
Cytorex® and Cytoreg® are Registered Trademarks of Cytorex International, Inc. and Cytorex Biosciences, Inc.